| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/02/2005 | EP1266025A4 Protein scaffolds for antibody mimics and other binding proteins |
| 02/02/2005 | EP1240200A4 Separation of fibrinogen from plasma proteases |
| 02/02/2005 | EP1135166B9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2005 | EP1131343A4 Hydrophilic somatostatin analogs |
| 02/02/2005 | EP1100523A4 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP1073718A4 Nucleic acids that control seed and fruit development in plants |
| 02/02/2005 | EP1064014B1 Medicament for preventing or treating papilloma virus-specific tumors |
| 02/02/2005 | EP0981610B1 Compositions for treatment of disorders involving programmed cell death |
| 02/02/2005 | EP0966534B1 Compositions and methods for elimination of unwanted cells |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0826031B1 Ataxia-telangiectasia gene and its genomic organization |
| 02/02/2005 | EP0781143B1 Method of blocking the sec receptor |
| 02/02/2005 | EP0761683B1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0613495B1 Transgenic non-human animals lacking prion proteins |
| 02/02/2005 | EP0606437B1 Non-shedding live herpesvirus vaccine |
| 02/02/2005 | CN1575340A Compositions and methods for treating neurodegenerative diseases |
| 02/02/2005 | CN1575338A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575334A Pathogen for bacterial poultry disease |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |
| 02/02/2005 | CN1575301A Administration of nucleic acid sequence to female animal |
| 02/02/2005 | CN1572876A Glyt1 conditional knock-out mice |
| 02/02/2005 | CN1572874A Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 02/02/2005 | CN1572799A Novel severe respiratory tract syndrome coronary virus protein and its antibody and uses |
| 02/02/2005 | CN1572798A SARS coronary virus related polypeptide and its uses |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572322A Attenuated live neospora vaccine |
| 02/02/2005 | CN1572321A Preparation of alpha-1 protein inhibitor |
| 02/02/2005 | CN1187451C Method of making proteins in transformed yeast cells |
| 02/02/2005 | CN1187447C MPL ligand analogs |
| 02/02/2005 | CN1187372C Synthetic chimeric peptide of human chorionic gonadotrophin genetic engineering and its preparation method |
| 02/02/2005 | CN1187371C Method for preparing phycocyanin of sea water |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/02/2005 | CN1187088C Chimeric flavirirus vaccines |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/01/2005 | US6849782 Arabidopsis antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 02/01/2005 | US6849780 Plants resistant to cucumber mosaic virus strain V34 |
| 02/01/2005 | US6849779 Method for producing high methionine corn seeds |
| 02/01/2005 | US6849728 Nucleic acid sequences encoding for glucose transporter (GLUT) proteins and the use of these proteins and nucleic acids in therapeutic, preventive, genetic counseling, and reagent screening applications |
| 02/01/2005 | US6849727 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 02/01/2005 | US6849721 Modifications of the VEGF receptor-2 protein and methods of use |
| 02/01/2005 | US6849719 Antibody to an IL-17 receptor like protein |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849717 Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon |
| 02/01/2005 | US6849712 Includes a C-terminal aromatic amino acid residue and an amino acid residue having a lipophilic alkyl side chain as the penultimate C-terminal residue |
| 02/01/2005 | US6849710 Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 02/01/2005 | US6849708 Insulinotropic hormone and uses thereof |
| 02/01/2005 | US6849603 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |
| 02/01/2005 | US6849600 For therapy of proliferative disorders of the skin and other tissues |
| 02/01/2005 | US6849596 Regulatory/unfolding peptides of ezrin |
| 02/01/2005 | US6849594 An enzyme-linked immunosorbent assay kit comprising a gene expressed proteins from culturing the cells; for repairing or producing cartilage implants |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849450 Antibodies to the metalloproteinase inhibitor |
| 02/01/2005 | US6849449 Orphanin FQ receptor nucleic acids |
| 02/01/2005 | US6849448 Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene |
| 02/01/2005 | US6849447 Protective recombinant Haemophilus influenzae high molecular weight proteins |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849429 Viral pseudo-capsids including assembly agonists and antagonists |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849417 Mammalian selenoprotein differentially expressed in tumor cells |
| 02/01/2005 | US6849415 TRAF-3 deletion isoforms and uses thereof |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849405 Incorporated into expression vectors to enhance recombinant protein production |
| 02/01/2005 | US6849399 Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| 02/01/2005 | US6849279 Glycoprotein; solvent extraction; prevention pollution, ultraviolet radiation damage |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 02/01/2005 | CA2248140C Assay and reagents for quantifying hbnp |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/28/2005 | CA2469094A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 01/27/2005 | WO2005008251A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis |
| 01/27/2005 | WO2005008248A2 Diagnosis and treatment of cervical cancer |
| 01/27/2005 | WO2005007891A2 Variants of human taste receptor genes |
| 01/27/2005 | WO2005007877A2 Regulatable promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007856A1 Assays for novel serotonin transporter (sert) blockers |
| 01/27/2005 | WO2005007836A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | WO2005007831A2 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 01/27/2005 | WO2005007829A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | WO2005007824A2 Mutants of vaccinia virus as oncolytic agents |
| 01/27/2005 | WO2005007811A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | WO2005007804A2 Anthrax conjugate vaccine and antibodies |
| 01/27/2005 | WO2005007701A1 Intensified fusion protein fv-ldp-ae having angiogenesis inhibiting and antitumor activety and the use thereof |
| 01/27/2005 | WO2005007694A1 HER2/neu PEPTIDE AND THERAPEUTIC USE TEHREOF |
| 01/27/2005 | WO2005007693A1 Design and use of kazal-type |
| 01/27/2005 | WO2005007691A2 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | WO2005007690A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | WO2005007689A1 Alphavirus-based cytomegalovirus vaccines |
| 01/27/2005 | WO2005007688A2 Human prostaglandin fp receptor variants and methods of using same |
| 01/27/2005 | WO2005007687A1 Compositions and methods for modulating ovarian follicular initiation |
| 01/27/2005 | WO2005007686A1 Rna binding peptide |
| 01/27/2005 | WO2005007683A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 01/27/2005 | WO2005007682A2 A peptide and a pharmaceutical composition, and their medical applications |